Condition

Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Nemtabrutinib plus lisocabtagene maraleucel for relapsed or refractory CLL/SLL

  This will test whether adding the oral drug nemtabrutinib to lisocabtagene maraleucel (CAR T‑cell therapy) helps people with CLL/SLL that has come back or stopped responding to prior treatment.

  Recruiting Phase 2 Fred Hutchinson Cancer Center · Seattle, Washington · NCT07194980

• Zanubrutinib plus sonrotoclax for relapsed or refractory B‑cell non‑Hodgkin lymphoma in underrepresented racial and ethnic groups

  This phase 1 trial tests whether combining zanubrutinib and sonrotoclax can help adults from underrepresented racial and ethnic groups whose B‑cell non‑Hodgkin lymphoma has returned or not responded to prior treatment.

  Recruiting Phase 1 City of Hope Medical Center · Duarte, California · NCT06859008

Related topics

Quick answers

How many Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →